Cite
Buas MF, Gu H, Djukovic D, et al. Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma. Metabolomics. 2017;13(3)doi: 10.1007/s11306-016-1154-y.
Buas, M. F., Gu, H., Djukovic, D., Zhu, J., Onstad, L., Reid, B. J., Raftery, D., & Vaughan, T. L. (2017). Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma. Metabolomics : Official journal of the Metabolomic Society, 13(3), . https://doi.org/10.1007/s11306-016-1154-y
Buas, Matthew F, et al. "Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma." Metabolomics : Official journal of the Metabolomic Society vol. 13,3 (2017). doi: https://doi.org/10.1007/s11306-016-1154-y
Buas MF, Gu H, Djukovic D, Zhu J, Onstad L, Reid BJ, Raftery D, Vaughan TL. Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma. Metabolomics. 2017 Mar;13(3). doi: 10.1007/s11306-016-1154-y. Epub 2017 Jan 20. PMID: 28190989; PMCID: PMC5295138.
Copy
Download .nbib